Atrial Fibrillation

>

Latest News

First Rivaroxaban Generics (2.5 mg) Get FDA Approval / image credit ©samunella/stock.adobe.com
First Rivaroxaban Generics (2.5 mg) Get FDA Approval

March 5th 2025

The first low-dose rivaroxaban generic tablets to be FDA approved lead a field crowded with applications for formulations of all the higher doses.

Atrial Fibrillation More Prevalent in US Than Previously Estimated: Daily Dose / image credit: ©New Africa/AdobeStock
Atrial Fibrillation More Prevalent in US Than Previously Estimated: Daily Dose

September 26th 2024

Individuals with Atrial Fibrillation Who Use Wearable Devices Report Heightened Symptom Monitoring, Treatment Concerns
Individuals with Atrial Fibrillation Who Use Wearable Devices Report Heightened Symptom Monitoring, Treatment Concerns

July 22nd 2024

Atrial Fibrillation May be More Common in Younger Adults than Previously Thought: Daily Dose / image credit: ©New Africa/AdobeStock
Atrial Fibrillation May be More Common in Younger Adults than Previously Thought: Daily Dose

May 2nd 2024

New Data Suggest Atrial Fibrillation May be More Common in Younger Adults than Previously Thought / Image credit: ©Horacio Selva/AdobeStock
New Data Suggest Atrial Fibrillation May be More Common in Younger Adults than Previously Thought

April 23rd 2024

<1
...
2930313233
© 2025 MJH Life Sciences

All rights reserved.